January 8, 2021 11:30 am – 2:25 pm EST
Fred Roberts, CCICADA Center, Rutgers University (Chair)
Juergen Richt, CEEZAD Center, Kansas State University (co-Chair)
Randy “Church” Kee, ADAC Center, University of Alaska
PROGRAM (*All times are in EST*)
11:30-11:35 AM: Welcome and Opening Remarks:
Jennifer Foley, Deputy Director, DHS Office of University Programs
Fred Roberts, CCICADA Center, Rutgers University
Juergen Richt, CEEZAD Center, Kansas State University
11:35-11:55 AM: Keynote 1
General Joseph Votel, CEO, Business Executives for National Security
11:55-12:05 PM: Q&A
12:05 PM-12:25PM: Keynote 2
Brian Strom, MD, MPH, Chancellor, Rutgers University Biomedical and Health Sciences Slides
12:35PM-1:25PM: Panel I: Distribution, Allocation, Administration, and Roles of Government and the Private Sector
Moderator: Fred Roberts, CCICADA Center Rutgers University
David Adinaro, MD, FACEP, Deputy Commissioner of Public Health Services, New Jersey Department of Health Slides
Kevin Ban, MD, Chief Medical Officer, Walgreens
Karin Shanahan, SVP, Merck Slides
Marion Whicker, Deputy Chief of Supply, Production and Distribution, Operation Warp Speed Slides
1:35PM-2:25PM: Panel II: Supply Chain Issues
Moderator: Fred Roberts, CCICADA Center Rutgers University
Leonardo (Len) DeCandia, Chief Procurement Officer, Johnson & Johnson Slides
Brandon Fried, Executive Director, Air Forwarders Association Slides
Reggie Jackson, Senior Manager Supply Chain Security, Pfizer
Jere Miles, Department of Homeland Security, Homeland Security Investigations
Edward (Ted) Smith, Alaska Native Tribal Health Consortium, and Shellie Martin, Kodiak Area Native Association Slides
Program and Bios:
Introductory Remarks: Jennifer Foley, Deputy Director, DHS Office of University Programs
Bio: Jennifer Foley
Ms. Foley is the Deputy Director, Office of University Programs (OUP). Through the Department of Homeland Security’s Centers of Excellence, OUP streamlines access to the expertise of the nation’s colleges and universities to address pressing homeland security needs. Ms. Foley also manages the Criminal Investigations and Network Analysis (CINA) Center of Excellence, a multidisciplinary academic consortium led by George Mason University, that pursues innovative strategies and solutions to advance criminal network analysis, forensics, and investigative processes. Prior to joining the Office of University Programs, Ms. Foley managed social science-focused research and development projects in terrorism prevention (with a focus on risk assessment), human trafficking, and child exploitation. In 2017, she launched S&T’s first program dedicated to human trafficking. Sample research efforts included: Risk Assessment for Terrorism Prevention; Reducing Recidivism Among Terrorism-related Offenders; Human Trafficking and Modern Slavery Foundational Effort; Human Trafficking Systems Analysis and Technology Roadmap; and Identifying Challenges and Opportunities to Support Law Enforcement Operations to Combat Internet Crimes against Children.
Ms. Foley received a Juris Doctor from the Catholic University of America, Columbus School of Law, and a Master of Arts in Forensic Psychology from John Jay College of Criminal Justice.
Introductory Remarks: Fred Roberts, Director, COE COVID-19 Supply Chain Initiative, Director of CCICADA COE
Bio: Fred Roberts
FRED S. ROBERTS is a Distinguished Professor of Mathematics at Rutgers University and Director of the Command, Control, and Interoperability Center for Advanced Data Analysis (CCICADA), founded as a University Center of Excellence of DHS. He is Emeritus Director of DIMACS, one of the original National Science Foundation science and technology centers, with 14 academic and industrial partners and some 350 affiliated scientists. Among his current research interests are resilience of supply chains, challenges of disasters and pandemics, stadium and large venue security, resource allocation, maritime cyber security, and the homeland security aspects of global environmental change. Roberts has authored four books, edited 24 additional books, and authored 200 scientific articles, some translated into Russian and Chinese, included the first book on maritime cyber security. Among his awards are the Commemorative Medal of the Union of Czech Mathematicians and Physicists, the Distinguished Service Award of the Association of Computing Machinery Special Interest Group on Algorithms and Computation Theory, Fellow of the American Mathematical Society, the National Science Foundation Science and Technology Centers Pioneer Award, and an honorary doctorate from the University of Paris-Dauphine.
Introductory Remarks: Juergen Richt, Director, Director of CEEZAD COE
Bio: Juergen A. Richt, DVM, PhD
Dr. Richt came to Kansas State University in 2008 as The Regents Distinguished Professor and Kansas Bioscience Eminent Scholar. In 2010, he became Director of the Department of Homeland Security (DHS) Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) and in 2020 Director of the National Institutes of Health (NIH) Center on Emerging and Zoonotic Infectious Diseases (CEZID). He received his Doctorate in Veterinary Medicine (DVM) from the University of Munich and a PhD in Virology and Immunology from the University of Giessen, both in Germany. After coming to the United States in 1989, he completed three years of postdoctoral/residency studies at The Johns Hopkins University and later served for eight years as a Veterinary Medical Officer at the National Animal Disease Center (USDA-ARS) in Ames, Iowa. He has edited several books, published more than 250 peer-reviewed manuscripts and raised more than $50 million in grants for veterinary research.
Dr. Richt is a pioneer in veterinary science, most notably in the “One Health” field. His work on high consequence pathogens with zoonotic and transboundary potential led to strategies to identify, control and/or eradicate such agents. His basic and applied research includes studies on animal influenza viruses, animal prion diseases including bovine spongiform encephalopathy (BSE), Rift Valley Fever virus (RVFV), African Swine fever virus (ASFV) and Borna Disease virus (BDV). Dr. Richt established the first reverse genetics system for swine influenza virus (SIV), and made seminal contributions to the development of a modified live SIV vaccine now sold in the U.S. as “Ingelvac Provenza™” and to understanding the virulence of the reconstructed 1918 “Spanish Flu” virus in livestock. He identified an atypical BSE case with a causative mutation (“genetic BSE”), used gene-editing approaches to develop the first prion protein knock-out cattle which are resistant to prion infection, and provided valuable information on host range of animal prions essential for risk analysis. Dr. Richt’s RVFV work led to the development of novel domestic and wild ruminant models for RVF and a safe, efficacious, and DIVA compatible subunit vaccine which is presently undergoing USDA licensure. For ASFV, he is developing subunit and modified live virus vaccine candidates as well as Point-of- Need diagnostics (PenCheckTM) to protect swine from this devastating disease. His recent work focused on the establishment of preclinical animal models for COVID-19 in cats, hamsters and ferrets. As founding Director of the DHS CEEZAD and the NIH CEZID Centers, he is supporting NIH, DHS and USDA in protecting public health and U.S. agricultural systems from devastating animal and zoonotic diseases.
Bio: General Joseph Votel
Continuing his long, distinguished career of service and senior leadership, General Votel today serves as President and CEO of Business Executives for National Security (BENS) – a national, nonprofit comprised of senior business and industry executives who volunteer their time and expertise to assist the U.S. national security community. In this role, General Votel leads a driven, multidisciplinary staff – spread across seven regional offices – and advises and executes on the strategy put forth by the BENS Board of Directors and the organization’s 400+ dedicated members.
General Votel joined BENS in January 2020 following a 39-year military career where he commanded special operations and conventional forces at every level; last serving as the Commander of U.S. Central Command (CENTCOM) where he was responsible for U.S. and coalition military operations in the Middle East, Levant, and Central and South Asia. General Votel’s career included combat in Panama, Afghanistan, and Iraq. And he notably led the 79-member coalition that successfully liberated Iraq and Syria from the Islamic State Caliphate. General Votel preceded his assignment at CENTCOM with service as the Commander of U.S. Special Operations Command and the Joint Special Operations Command.
General Votel has been recognized with the Distinguished Military Leadership Award from the Atlantic Council and has received the U.S.- Arab Defense Leadership Award from the National Council on U.S.-Arab Relations; the Patriot Award from the National Medal of Honor Society; the SGT James T. Regan Lifetime Achievement Award from the “Lead the Way” Foundation; and the Freedom Award from the Intrepid Sea, Air and Space Museum.
He is a Strategic Advisor for Sierra Nevada Corporation as well as a member of the Board of Trustees for Noblis Corporation. Votel is a non-resident Distinguished Fellow at the Middle East Institute in Washington, DC and the Belfer Center at the John F. Kennedy School of Government in Cambridge, MA. He sits on the Executive Board of the Center for Ethics and the Rule of Law (CERL) at the University of Pennsylvania Law School and is an Advisor to the Combating Terrorism Center at West Point, NY. He serves on the Board of Directors for both Service to School and Minnesota Wire and also serves as an Advisor to the Texas Transition Network. He is a member of the Council on Foreign Relations.
General Votel is a 1980 graduate of the United States Military Academy and earned his Master’s Degrees from the U.S. Army Command and Staff College and the Army War College. He and his wife Michele – who reside in Lake Elmo, Minnesota – have two adult sons, a daughter-in-law, and two grandchildren.
Keynote 2: Brian Strom, MD, MPH, Chancellor, Rutgers University Biomedical and Health Sciences
Slides Bio: Brian L. Strom, MD, MPH – As Inaugural Chancellor of Rutgers Biomedical and Health Sciences and the Executive Vice President for Health Affairs at Rutgers University, Dr. Strom has spearheaded the creation of an interprofessional faculty practice group; established a formal partnership with RWJBarnabas Health to create the New Jersey’s largest and most comprehensive academic health system; and led a major recruitment drive to bring the nation’s most talented biomedical researchers and clinicians to Rutgers. Prior to joining Rutgers, Dr. Strom was the Executive Vice Dean for Institutional Affairs, Founding Chair of the Department of Biostatistics and Epidemiology, Founding Director of the Center for Clinical Epidemiology and Biostatistics, and Founding Director of the Graduate Program in Epidemiology and Biostatistics, at the Perelman School of Medicine of the University of Pennsylvania. In addition to writing more than 650 papers and 15 books, he has been principal investigator for more than 275 grants, including over $115 million in direct costs alone. He was honored as one of the Best Doctors in America, for each of his last eight years at Penn.
Dr. Strom’s major research interest is in the field of pharmacoepidemiology, the application of epidemiologic methods to the study of drug use and effects. He is recognized as a founder of this field and for his pioneering work in using large databases for research. He is editor of the field’s major text (now in its sixth edition) and Editor-in-Chief for Pharmacoepidemiology and Drug Safety, the official journal of the International Society for Pharmacoepidemiology.
Dr. Strom was a member of the Board of Regents of the American College of Physicians, the Board of Directors of the American Society for Clinical Pharmacology and Therapeutics, and the Board of Directors for the American College of Epidemiology, the Board of Directors for the Association for Patient-Oriented Research, and the Board of Directors of the Clinical Research Forum. He was previously President of the International Society for Pharmacoepidemiology and the Association for Clinical Research Training.
Dr. Strom was on the Drug Utilization Review Committee and the Gerontology Committee of the United States Pharmacopoeia, served on the Drug Safety and Risk Management Advisory Committee for the US Food and Drug Administration, chaired the Institute of Medicine (IOM) (now the National Academy of Medicine) Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, chaired the IOM Committee on Smallpox Vaccine Program Implementation, chaired the IOM Committee to Review NIOSH’s Traumatic Injury Program, chaired the IOM Committee on the Consequences of Reducing Sodium in the Population, chaired the IOM Committee on a National Strategy for the Elimination of Hepatitis B and C and the Committee on Development of a Protocol to Evaluate the Concomitant Prescribing of Opioid and Benzodiazepine Medications and Veterans Deaths and Suicides. Dr. Strom was a member of the IOM Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, and was a member of the IOM Committee on Standards for Developing Trustworthy Clinical Practice Guidelines and the IOM Drug Forum.
Dr. Strom is a member of the American Epidemiology Society, and is one of a handful of clinical epidemiologists elected to the American Society of Clinical Investigation and American Association of Physicians. He has been an elected member of the IOM of the National Academy of Medicine since 2001. He received the 2003 Rawls-Palmer Progress in Medicine Award and the 2016 Oscar B. Hunter Career Award in Therapeutics from the American Society for Clinical Pharmacology & Therapeutics, the Naomi M. Kanof Clinical Investigator Award of the Society for Investigative Dermatology, and in 2006 he received the Sustained Scientific Excellence Award from the International Society for Pharmacoepidemiology. In addition, he was named the 2008 recipient of the John Phillips Memorial Award for Outstanding Work in Clinical Medicine. This award is from the American College of Physicians (ACP) and is considered to be one of the highest awards in Internal Medicine. Dr. Strom also received the 2013 Association for Clinical and Translational Science/American Federation for Medical Research National Award for Career Achievement and Contribution to Clinical and Translational Science for translation from clinical use into public benefit and policy. Penn awards that Dr. Strom received included the Class of 1992 Class Teaching Award and the Samuel Martin Health Evaluation Sciences Research Award. Dr. Strom received the 2004 Christian R. and Mary F. Lindback Award, the University’s most prestigious teaching award, in recognition of the contribution he has made in his career to clinical research teaching. The 2016 Oscar B. Hunter Career Award in Therapeutics was awarded to Dr. Strom for his outstanding contributions to clinical pharmacology and therapeutics. In 2017, Dr. Strom was named Honorary President of The Hellenic Society of Pharmacoepidemiology and in 2018 he was awarded an honorary doctorate from the University of Thrace in Greece. In 2020 he was named as a Fellow of the American Association for the Advancement of Science (AAAS).
David Adinaro, MD, FACEP, Deputy Commissioner of Public Health Services, New Jersey Department of Health
Slides Bio: Dr. David Adinaro began serving as Deputy Commissioner for Public Health Services on June 18, 2020. As the Deputy Commissioner for Public Health Services, Dr. Adinaro will oversee the Divisions of Epidemiology, Environmental and Occupational Health; Family Health Services; HIV, STD and TB Services; Medicinal Marijuana; Public Health Infrastructure, Laboratories and Emergency Preparedness (PHILEP); and the Offices of Local Public Health and Women’s Health. The Division has 660 staff and a $103.5 million budget.
Dr. Adinaro became an EMT as a teenager and volunteered on first aid squads for 17 years including while a student at Rutgers -New Jersey Medical School in Newark. He graduated in 2000 and then completed his residency in Emergency Medicine at Morristown Medical Center in 2003. He is a graduate of Lehigh University’s Healthcare Systems Engineering professional master’s program and earned a Master of Arts in Education degree in 1993 from Seton Hall University.
He is a fellow of the American College of Emergency Physicians and is a former president, board member and education committee chair of its New Jersey chapter. He also served as the medical director for the Union County College Paramedic Training Program. Dr. Adinaro has lectured extensively in emergency medicine focusing on evidence-based medicine, simulation, patient safety and opioid prescribing in the Emergency Department and was the director of an innovative fellowship program in Administration and Informatics.
Kevin Ban, MD, Chief Medical Officer, Walgreens
Bio: Kevin Ban, MD, is a physician executive with more than two decades of clinical experience and a track record for optimizing clinical programs, healthcare information systems, and patient safety. Prior to joining Walgreens as Chief Medical Officer, Kevin served as Chief Medical Officer at athenahealth, driving collaborative and strategic initiatives with a specific focus on population health. A board-certified emergency medicine physician with over 24 years of clinical experience, he served as Beth Israel Deaconness Needham’s CMO, and was a member of Harvard Medical School’s academic faculty from 2003-2016. Kevin led the Tuscan Emergency Medicine Initiative from 2003-2010 — driving success in emergency medicine education, quality improvement, translational research, and simulation training in the region — and launched the first pediatric trauma center in Italy where he served as Chairman of the program. Kevin received his BA and MD from Georgetown University, and completed his Emergency Medicine training in the Beth Israel Deaconess Harvard Affiliated Emergency Medicine Residency program.
Leonardo (Len) DeCandia, Chief Procurement Officer, Johnson & Johnson
Slides Bio: Leonardo (Len) Decandia is Global Chief Procurement Officer at Johnson & Johnson (NYSE: JNJ), an $82 billion maker of pharmaceuticals, medical device and consumer health products with 140,000 employees around the world.
Len rejoined Johnson & Johnson in 2014 after a previous tenure from 1982 to 1996. He assumed his current role in 2016. As Chief Procurement Officer, he is responsible for all global procurement policies, including supplier base strategy development, practices such as relationship management and functional headcount. He also serves as a member of Johnson & Johnson’s enterprise governance and corporate governance councils. He spearheaded an enterprise-wide functional transformation, from a decentralized procurement system to a center-led model, covering all categories of spend for Johnson & Johnson globally. He also led the deployment of the world’s largest cloud-based procurement technology, which processed more than $50 billion in spend for a $5.2 billion cost savings in the first three years.
From 2009 to 2014, Len was Chief Procurement Officer and Senior Vice President for Estée Lauder (NYSE: EL), where he was accountable for all global procurement functions totaling $4.5 billion in spend, including direct materials and third-party manufacturing. He managed the deployment of all global strategies for major categories, such as chemicals, plastics, glass and packaging, leading the enterprise to a five-year cumulative savings of $722 million.
Previously, he was Senior Vice President, Supply Chain Management, at AmerisourceBergen (NYSE: ABC) from 2004 to 2008. He was responsible for all of AmerisourceBergen’s $51 billion procurement functions as well as $4 billion in inventory management activities involving the distribution of branded, generics and over-the-counter pharmaceutical products. He also held general management responsibility for the $4 billion generics business. Len is the founding chair (2002) of the Rutgers University Center for Supply Chain Management and he is currently a member of the advisory board at the Rutgers Business School. Len was also a previous chairman of the Healthcare Distribution Alliance industry board from 2006 to 2008.
Len holds a bachelor’s degree in Mechanical Engineering and a master’s degree in Business Administration from Rutgers University.
Brandon Fried, Executive Director, Air Forwarders Association
Slides Bio: Brandon Fried has more than 38 years of experience in the airfreight forwarding industry and is from Washington, D.C.
While still a forwarder, Brandon joined the Airforwarders Association and was soon elected Chairperson in 2001. He served two consecutive terms as Chair and remained an active member of the Board of Directors.
In November of 2005, Brandon was appointed to serve as the new executive director of the Airforwarders Association. As executive director, Brandon represents the Association on all security matters and serves several Federal Advisory Committees including:
- The TSA Aviation Security Advisory Committee
- The U.S. Department of Commerce Committee on Supply Chain Competitiveness
- CBP Commercial Operations Advisory Committee
He also now chairs and represents forwarder interests on the advisory Board of Cargo Network Services, an IATA company.
He advocates for the industry in the halls of Congress, the Department of Homeland Security and is the public face of the Airforwarders Association.
Brandon is a recognized expert on the air cargo industry and regularly comments for major trade publications such as American Shipper, The Journal of Commerce and Air Cargo World. He also continues to educate and advocate for forwarders in national publications, including the Washington Post, the Wall Street Journal, the Chicago Tribune, the Los Angeles Times, The Miami Herald and USA Today. He has also appeared on National Public Radio, CNN News and C-SPAN’s Washington Journal television shows.
A graduate of Syracuse University, Brandon holds a master’s degree in business administration and lives in Chevy Chase, Md. with his wife Kim and two children, Evan and Jordan.
Reggie Jackson, Senior Manager Supply Chain Security, Pfizer Global Security
Bio: Reggie Jackson, Product Monitoring Lead, Pfizer Global Security
Reggie has worked for Pfizer for 20 years. For the last 6 years, Reggie has worked and led the efforts around Supply Chain Security for Pfizer globally. These duties include preventing, detecting and responding to incidents of theft, counterfeiting, diversion, and adulteration of all Pfizer products intended for the legitimate supply chain. He is the Supply Chain Security Steering Committee chair for Rx-360 and sits on Rx-360’s Board of Directors. Reggie has a BS in Chemical Engineering and an MBA from North Carolina State University and lives in Raleigh, NC.
Shellie Martin, Kodiak Area Native Association
Slides Bio: Shellie Martin is a level III Certified Community Health Aide, Emergency Medical Technician, and member of the Community Health Aide Program Association in the State of Alaska. She is employed by the Kodiak Area Native Association and has been a front-line worker for the past 3 ½ years, travelling between five remote villages in the Kodiak archipelago to provide primary health care and after hours emergency services to their residents.
The Alaska Community Health Aide Program has improved remote access to healthcare for rural Alaskans living in Native village communities by developing a paraprofessional workforce. The structured progressive training for the Community Health Aide Program has created a clinically competent group of women and men who make up the backbone of primary rural health care in our state. Shellie is proud to be a part of a program that allows her to grow her clinical skills, learn and participate in Alutiiq culture, travel to beautiful places, and contribute to her community in a meaningful way.
Jere Miles, Department of Homeland Security, Homeland Security Investigations
Bio: Jere Miles
Jere Miles is the Assistant Director (AD), Operational Technology and Cyber Division, Homeland Security Investigations, Washington, DC. In his current assignment he exercises oversight of the enterprise wide Law Enforcement Technology; uses, R&D, purchasing and deployment, the global Cyber Investigations program; policy development, implementation and oversight as well as training of all cyber investigators and analysts dedicated to cyber forensics, intrusions or digital technology facilitated criminal activity. Additionally, he oversees HSI’s enterprise wide investigative databases, big data project and global information sharing.
Prior to beginning his career as a Federal Criminal Investigator, SAC Miles served in the United States Army’s 82nd Airborne Division, from 1984 until 1992, participating in Operation “Just Cause”. After his honorable discharge, he served as a Deputy Sheriff in South Carolina from 1993 – 1999, holding the positions of Patrol Deputy, Vice Detective and Resident Deputy Investigator.
He began his federal career in November 1999, with the U.S. Customs Service as an Air Enforcement Officer. In December 2000, he was converted to a Criminal Investigator and assigned to work in the U.S. Customs Service (USCS), Special Agent in Charge (SAC), Miami, FL. During his Federal career AD Miles has spent seven years overseas, Republic of Mexico, and held numerous leadership positions in both Homeland Security Investigations field offices and Headquarters.
Karin Shanahan, SVP, Merck
Slides Bio: Karin Shanahan
Karin has nearly 25 years of experience in the pharmaceutical industry, beginning her pharma career with Bristol-Myers Squibb in their global supply chain organization. Working with a cross-functional team, Karin helped Bristol-Myers Squibb design the Product Development & Commercialization process; later leading the launch readiness for the Abilify launch. She moved into manufacturing operations to lead two manufacturing operations, first a radio-pharmaceutical operation in Billerica, MA and then the networks’ largest API and DP site in Latina, Italy. She left BMS to join Becton Dickenson as VP, Global Operations supporting their Pre-Analytical Services business unit. After a brief role with Catalent Pharmaceuticals, she moved to Teva Pharmaceutical as SVP, Americas & EU Sterile Operations where she had responsibility for 24 sites in Canada, US, Latin America and Europe. During her 5 years at Teva, Karin created the MS&T (Manufacturing, Science & Technology) organization to enhance product launch capabilities, took on responsibility for network strategy and was globally responsible for Operational Excellence. She recently joined Merck as SVP, Global Biologics and Sterile Operations where she has operational responsibility for Keytruda and an IO pipeline of products. In this role, she is also accountable to supply several vaccines, most notably Gardasil. Prior to joining the pharma industry, she held supply chain roles at Daimler Benz and the U.S. military in her hometown of Berlin, Germany. She holds a BA in Political Science & International Relations from Rutgers University and is earning her MSJ in Pharmaceutical and Device Law at Seton Hall University. She currently resides in New Jersey with her husband, Tim, and two daughters, Sarah (18) and Kathryn (17).
Edward (Ted) Smith, Alaska Native Tribal Health Consortium
Slides Bio: Edward (Ted) Smith, Tribal Health Emergency Preparedness Manager, Alaska Native Tribal Health Consortium (ANTHC). Mr. Smith has seventeen years of emergency preparedness/response experience in the State of Alaska. He is currently responsible for the coordination and development of emergency plans and programs for ANTHC, Tribal hospitals, clinics, tribes and Alaska communities. Prior to his work for ANTHC he served as an Emergency Planner for the Department of Health & Social Services’ (DHSS) Section of Emergency Programs. His primary responsibilities included providing technical assistance for all departmental emergency planning needs, teaching/advising on emergency management issues at the community level, and he served as the State’s Coordinator for the Strategic National Stockpile and the Hospital Preparedness Program. Previous to this position, Mr. Smith worked for the Alaska Division of Homeland Security and Emergency Management (DHS&EM) as an Emergency Management Specialist.
Marion Whicker, Deputy Chief of Supply, Production and Distribution, Operation Warp Speed
Slides Bio: Ms. Marion Whicker was selected to the Senior Executive Service in June 2018, and is currently serving as the Executive Director of the Integrated Logistics Support Center (ILSC), U.S. Army Tank-automotive and Armaments Command. In this position, Ms. Whicker oversees the readiness of the majority of Army maintenance, fielding, new equipment training, supply chain management and system readiness. Ms. Whicker has direct oversight for a major Integrated Materiel Management Center with over 3,200 combined military and civilians. She provides the senior leader logistical support to almost 500 (63% of the Army’s) new acquisition programs, as well as the sustainment support for over 10,000 major end items, ensuring operational readiness and support to the majority of the Army’s major weapon systems. She provides leadership of a major logistics organization to include Weapon Systems Program Management, Materiel Management, Maintenance, Customer Support/Readiness, Integrated Logistic Support, and logistics support to five Program Executive Offices and associated Program/Project/Product Manager Offices.